Association between metabolic syndrome and late saphenous vein graft disease

Basit Öğe Kaydı
dc.authoridYilmaz, Mehmet Birhan/0000-0002-8169-8628
dc.authoridGURAY, UMIT/0000-0002-6604-2970
dc.contributor.authorYilmaz, Mehmet Birhan
dc.contributor.authorGuray, Umit
dc.contributor.authorGuray, Yesim
dc.contributor.authorBiyikoglu, Senay Funda
dc.contributor.authorKisacik, Halil L.
dc.contributor.authorKorkmaz, Sule
dc.date.accessioned2024-10-26T18:06:00Z
dc.date.available2024-10-26T18:06:00Z
dc.date.issued2006
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstractObjectives: Saphenous vein grafts have been widely used in coronary bypass operations for many years. We investigated the association between metabolic syndrome (MS) and late saphenous graft disease. Study design: The study included 193 patients (16 females, 177 males; mean age 62 +/- 8 years; range 39 to 86 years) in whom at least one saphenous vein graft had been used during coronary bypass operation of at least 10-year history. All the patients underwent coronary angiography for anginal complaints or preoperative assessment. Patients were classified into two groups. Group 1 was comprised of 72 patients with patent saphenous graft, whereas group 2 included 121 patients without patency or with associated lesions. The two groups were compared in terms of their medications, anthropometric measurements, blood biochemistry, and the presence of hypertension, diabetes mellitus, smoking, and MS. Results: Metabolic syndrome was less frequent in group 1 than in group 2 (22% vs. 45.6%, p=0.003). Metabolic syndrome score, derived from the sum of MS components, was higher in group 2 than in group 1 (2.3 +/- 1 vs. 1.8 +/- 1.2, p=0.003). In a multivariate logistic regression analysis, duration from bypass to coronary angiography (beta=0.812, p=0.017) and MS score (beta=0.590, p=0.005) were found to be independent factors related to saphenous graft patency. Conclusion: Metabolic syndrome score seems to be associated with late saphenous vein graft disease. Early measures for MS may affect the prognosis of patients undergoing coronary bypass operations.
dc.identifier.endpage165
dc.identifier.issn1016-5169
dc.identifier.issue3
dc.identifier.scopus2-s2.0-39849100089
dc.identifier.scopusqualityQ4
dc.identifier.startpage162
dc.identifier.urihttps://hdl.handle.net/20.500.12418/29276
dc.identifier.volume34
dc.identifier.wosWOS:000421483600003
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isotr
dc.publisherTurkish Soc Cardiology
dc.relation.ispartofTurk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectCoronary artery bypass
dc.subjectgraft occlusion
dc.subjectvascular/etiology
dc.subjectmetabolic syndrome X/complications
dc.subjectsaphenous vein/transplantation
dc.subjectvascular patency
dc.titleAssociation between metabolic syndrome and late saphenous vein graft disease
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu